Han JY - Search Results

1

9-cis-retinoic acid treatment increases serum concentrations of alpha-tocopherol in former smokers.

Han JY, Liu DD, Lee JJ, Kurie J, Lotan R, Hong WK, Lee HY. Han JY, et al. Clin Cancer Res. 2005 Mar 15;11(6):2305-11. doi: 10.1158/1078-0432.CCR-04-2074. Clin Cancer Res. 2005. PMID: 15788681 Clinical Trial.

2

Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers.

Lee DH, Han JY, Lee HG, Lee JJ, Lee EK, Kim HY, Kim HK, Hong EK, Lee JS. Lee DH, et al. Among authors: han jy. Clin Cancer Res. 2005 Apr 15;11(8):3032-7. doi: 10.1158/1078-0432.CCR-04-2149. Clin Cancer Res. 2005. PMID: 15837758 Clinical Trial.

3

Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers.

Lee HY, Chang YS, Han JY, Liu DD, Lee JJ, Lotan R, Spitz MR, Hong WK. Lee HY, et al. Among authors: han jy. J Clin Oncol. 2005 Jul 1;23(19):4439-49. doi: 10.1200/JCO.2005.04.572. J Clin Oncol. 2005. PMID: 15994153

4

Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.

Han JY, Oh SH, Morgillo F, Myers JN, Kim E, Hong WK, Lee HY. Han JY, et al. J Natl Cancer Inst. 2005 Sep 7;97(17):1272-86. doi: 10.1093/jnci/dji251. J Natl Cancer Inst. 2005. PMID: 16145048

5

A phase II study of irinotecan plus cisplatin for patients with advanced stage IIIB or IV NSCLC previously treated with nonplatinum-based chemotherapy.

Kim HT, Han JY, Lee DH, Chun JH, Lee HG, Lee JJ, Kim HY, Lee SY, Lee JS. Kim HT, et al. Among authors: han jy. Cancer. 2006 Aug 15;107(4):799-805. doi: 10.1002/cncr.22063. Cancer. 2006. PMID: 16826586 Free article. Clinical Trial.

6

Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer.

Lee DH, Kim SK, Lee HY, Lee SY, Park SH, Kim HY, Kang KW, Han JY, Kim HT, Lee JS. Lee DH, et al. Among authors: han jy. J Thorac Oncol. 2009 Jul;4(7):816-21. doi: 10.1097/JTO.0b013e3181a99fde. J Thorac Oncol. 2009. PMID: 19487962 Free article.

7

Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy.

Lee YJ, Yoon KA, Han JY, Kim HT, Yun T, Lee GK, Kim HY, Lee JS. Lee YJ, et al. Among authors: han jy. Clin Cancer Res. 2011 Aug 1;17(15):5179-87. doi: 10.1158/1078-0432.CCR-11-0400. Epub 2011 Jun 8. Clin Cancer Res. 2011. PMID: 21653691 Clinical Trial.

8

A Phase II study of weekly irinotecan and capecitabine in patients with previously treated non-small cell lung cancer.

Han JY, Lee DH, Kim HY, Kim EA, Lee JJ, Ju SY, Shin EH, Lee JS. Han JY, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5909-14. Clin Cancer Res. 2003. PMID: 14676114 Clinical Trial.

9

Randomized Phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinoma.

Han JY, Lim HS, Lee DH, Ju SY, Lee SY, Kim HY, Park YH, Park CG, Lee JS. Han JY, et al. Cancer. 2006 Feb 15;106(4):873-80. doi: 10.1002/cncr.21668. Cancer. 2006. PMID: 16411223 Free article. Clinical Trial.

10

A randomized phase II study of gefitinib plus simvastatin versus gefitinib alone in previously treated patients with advanced non-small cell lung cancer.

Han JY, Lee SH, Yoo NJ, Hyung LS, Moon YJ, Yun T, Kim HT, Lee JS. Han JY, et al. Clin Cancer Res. 2011 Mar 15;17(6):1553-60. doi: 10.1158/1078-0432.CCR-10-2525. Clin Cancer Res. 2011. PMID: 21411446 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,095 results

Search Page

Filters